Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 in Dry Eye Disease Associated with Meibomian Gland Dysfunction Medical Device Investing
Japan's MHLW Approves Pfizer's CIBINQO® for Adults and Adolescents with Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
Merck Announces Appointment of Thomas H. Glocer as Independent Lead Director Pharmaceutical Investing
CSE Bulletin: Fundamental Change - Glenbriar Technologies Inc./Love Pharma Inc. Life Science Investing
Positive Top-line Results of Pfizer's Phase 3 Study Exploring Coadministration of Prevnar 20 With Seasonal Flu Vaccine in Older Adults Released Pharmaceutical Investing
FDA Approves QULIPTA , the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine Biotech Investing
Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSD Cannabis Investing News
Merck to Hold Third-Quarter 2021 Sales and Earnings Conference Call on October 28 Pharmaceutical Investing
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age Video Interview
